Biotechnology

Filter

Current filters:

None

Popular Filters

1 to 25 of 2429 results

Novartis venture fund leads $34 million financing for Annexon Bioscience

Novartis venture fund leads $34 million financing for Annexon Bioscience

17-12-2014

USA-based Annexon Bioscience says it has closed a $34 million Series A-1 to support the development of…

Annexon BioscienceANX005BiotechnologyFinancialNeurologicalNovartis

CMC Biologics and OncoSynergy link on Ebola drug development and manufacture

CMC Biologics and OncoSynergy link on Ebola drug development and manufacture

16-12-2014

Denmark and USA-based contract manufacturers CMC Biologics and US biopharma start-up OncoSynergy have…

Anti-viralsBiotechnologyCMC BiologicsOncoSynergyOS2966ProductionResearchTropical diseases

Neovacs' Phase IIb study of TNF-Kinoid in rheumatoid arthritis fails to meet primary endpoints

Neovacs' Phase IIb study of TNF-Kinoid in rheumatoid arthritis fails to meet primary endpoints

16-12-2014

French autoimmune specialist Neovacs says that its Phase IIb trial of TNF-Kinoid in rheumatoid arthritis…

BiotechnologyFranceImmunologicalsNeovacsResearchTNF-Kinoid

Curie-Cancer renews research partnership with GamaMabs Pharma for ovarian cancer drug

Curie-Cancer renews research partnership with GamaMabs Pharma for ovarian cancer drug

16-12-2014

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities,…

BiotechnologyFranceGamaMabs PharmaOncologyResearch

Anthera Pharma licenses Japan rights for blisibimod to Zenyaku Kogyo

Anthera Pharma licenses Japan rights for blisibimod to Zenyaku Kogyo

16-12-2014

US development-stage biophama company Anthera Pharmaceuticals has entered into an exclusive licensing…

AmgenAnthera PharmaceuticalsBiotechnologyblisibimodJapanLicensingOncologyZenyaku Kogyo

Sophiris Bio shares slide on Phase III results of PRX302

Sophiris Bio shares slide on Phase III results of PRX302

16-12-2014

Biotech company Sophiris Bio saw shares in the company fall up to almost 80% following an announcement…

BiotechnologyMen's HealthPRX302ResearchSophiris Bio

Astellas Venture Management invests in Crescendo's Humabody antibody fragment project

Astellas Venture Management invests in Crescendo's Humabody antibody fragment project

16-12-2014

UK-based antibody therapeutics specialist Crescendo Biologics has received another equity investment…

BiotechnologyBusiness FinanceCrescendo BiologicsOncologyUK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

16-12-2014

A new biomedical laboratory, the Biomedical Innovation Hub (the BioHub) has opened in Birmingham, UK.

BiotechnologyBirminghamResearchUKUnited Kingdom

Sorrento to partner with Nantworks founder Patrick Soon-Shiong on immunomodulatory antibodies

Sorrento to partner with Nantworks founder Patrick Soon-Shiong on immunomodulatory antibodies

15-12-2014

Oncology specialist Sorrento Therapeutics has entered into a binding agreement with medical technology…

BiotechnologyLicensingOncologyResearchSorrento TherapeuticsUSA

Genentech files NDA for cobimetinib with Zelboraf in advanced melanoma

Genentech files NDA for cobimetinib with Zelboraf in advanced melanoma

15-12-2014

Genentech, the US biotech subsidiary of Swiss Pharma major Roche Group, has submitted a New Drug Application…

BiotechnologycobimetinibExelixisGenentechOncologyRegulationRocheUSAZelboraf

Gilead appoints Philippe Bishop as senior vice president of hematology and oncology therapeutics

Gilead appoints Philippe Bishop as senior vice president of hematology and oncology therapeutics

15-12-2014

US biotech major Gilead Sciences has appointed Philippe Bishop as senior vice president of hematology…

BiotechnologyBoardroomGilead SciencesHematologyOncologyUSA

Ignyta and Nerviano amend license accord on entrectinib

Ignyta and Nerviano amend license accord on entrectinib

15-12-2014

US oncology focused biotech firm Ignyta has agreed to an amendment to its license agreement with Italy’s…

BiotechnologyentrectinibIgnytaLicensingNerviano Medical SciencesOncologyRXDX-101

Zealand Pharma's senior vice president Arvind Hundal steps down

Zealand Pharma's senior vice president Arvind Hundal steps down

15-12-2014

Denmark-based biotech company Zealand Pharma announced today that senior vice president and chief business…

Arvind HundalBiotechnologyBoardroomDenmarkZealand Pharma

Co-founder Joost Holthuis replaces founder as chief executive amid $7 million financing round

Co-founder Joost Holthuis replaces founder as chief executive amid $7 million financing round

15-12-2014

The co-founder of Dutch nanomedicine company Cristal Therapeutics, Joost Holthuis, has succeeded its…

BioGeneration VenturesBiotechnologyBoardroomCristal TherapeuticsNetherlands

NetScientific invests in PDS Biotechnology

NetScientific invests in PDS Biotechnology

15-12-2014

UK-based life sciences investor NetScientific has made an undisclosed investment in privately-held US…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsNetScientificOncologyPDS BiotechnologyUK

Plans unveiled for Singapore’s biologics manufacturing industry

Plans unveiled for Singapore’s biologics manufacturing industry

13-12-2014

The Singapore Workforce Development Agency (WDA), Singapore Economic Development Board (EDB) and Biopharmaceutical…

AbbVieAmgenBaxterBiotechnologyGlaxoSmithKlineLonzaNovartisProductionRocheSingapore

Valneva and BliNK Therapeutics launch new biotech company

Valneva and BliNK Therapeutics launch new biotech company

12-12-2014

France-based biotech firm Valneva and privately-held UK company BliNK Therapeutics have created a private…

BiotechnologyBliNK BiomedicalBliNK TherapeuticsFinancialFranceMergers & AcquisitionsUKValneva

Sosei to acquire Japanese peptide technology company Jitsubo

Sosei to acquire Japanese peptide technology company Jitsubo

12-12-2014

Japanese biopharma company Sosei says its board of directors has resolved to acquire existing shares…

BiotechnologyJapanJitsuboMergers & AcquisitionsSosei

Ardelyx appoints Jeremy Caldwell as executive vice president and chief scientific officer

Ardelyx appoints Jeremy Caldwell as executive vice president and chief scientific officer

11-12-2014

Biopharma commpany Ardelyx has appointed Jeremy Caldwell as executive vice president and chief scientific…

ArdelyxBiotechnologyBoardroomJeremy CaldwellUSA

Celgene appoints Wim Souverijns as vice president general manager for UK and Ireland

Celgene appoints Wim Souverijns as vice president general manager for UK and Ireland

11-12-2014

US biotech company Celgene has appointed Wim Souverijns as vice president general manager for the UK…

BiotechnologyBoardroomCelgene Corp.UKUK & Ireland

AusBiotech reflects on a year of advocacy and achievement

AusBiotech reflects on a year of advocacy and achievement

11-12-2014

For the Australian biotechnology industry and for trade group AusBiotech, the past year has been another…

AustraliaBiotechnologyFinancialPoliticsResearch

Navidea forms Macrophage Therapeutics unit to explore applications of Manocept

11-12-2014

US biotech firm Navidea Biopharmaceuticals has established a new business unit, Macrophage Therapeutics,…

BiotechnologyLymphoseekMacrophage TherapeuticsManagementManoceptNavidea BiopharmaceuticalsUSA

Biopharma market could be worth $41 billion this year, says Kalorama report

Biopharma market could be worth $41 billion this year, says Kalorama report

10-12-2014

Biopharma and vaccine production could be worth up to $41 billion this year, according to a report by…

BiologicBiotechnologyKaloramaKalorama InformationMarkets & Marketing

1 to 25 of 2429 results

Back to top